BioVie, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for BIVI, updated each market day.
BIVI AI Sentiment
AI predicts BioVie, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About BioVie, Inc. Common Stock
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Sector
Exchange
Market Cap
$10,858,656
Cap Tier
Employees
13
Headquarters
CARSON CITY, NV
Listed Since
Jan. 14, 2014
Website
BIVI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BIVI Volatility
BioVie, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
